Integrating Quality Measures in Type 2 Diabetes Management Opportunities to Improve Macrovascular Outcomes

Jointly sponsored by Medical Education Collaborative, Inc (MEC) and Princeton CME

Purpose Statement

This educational activity is designed to educate managed markets physicians, pharmacists, and nurses on the implementation and execution of quality measures to assist clinicians in improving management of type 2 diabetes and prevention of macrovascular disease.

Target Audience

This activity is designed for managed markets physicians, pharmacists, and nurses.

Learning Objectives

After completing this activity, participants should be able to:

Describe the prevalence and clinical and cost burden of type 2 diabetes and the impact of macrovascular complications
Summarize data on the safety and efficacy of pharmacologic approaches for the management of type 2 diabetes and prevention of macrovascular disease
Outline strategies to assist patients and providers in increasing compliance with type 2 diabetes management approaches
Integrate quality measures into managed markets practice to improve outcomes related to type 2 diabetes and macrovascular complications

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity—including Question and Answer session—complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants seeking CME credit who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Participants seeking CNE credit who successfully complete the post-test and evaluation form online will receive documentation of credit by mail within 6 weeks.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release date: May 20, 2008; Expiration date: May 20, 2009

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The presentation slides, Q&A session, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.

CME Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Collaborative, Inc (MEC) and Princeton CME. MEC is accredited by the ACCME to provide continuing medical education for physicians.

MEC designates this educational activity for a maximum of 1.0 AMA PRA Category 1Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding the ACCME accreditation of this activity, please contact MEC at 866-420-3252.

CNE Accreditation

Medical Education Collaborative, Inc (MEC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity for 1.0 contact hour is provided by MEC.

MEC is approved by the California Board of Registered Nursing, Provider Number 129909 for 1.0 contact hour.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UPN 452-999-08-014-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Continuing Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Grant Support

Supported by an educational grant from Takeda Pharmaceuticals North America, Inc

Participating Faculty

Barry J. Goldstein, MD, PhD, FACE
Professor of Medicine, Biochemistry and Molecular Pharmacology
Director, Division of Endocrinology, Diabetes, and Metabolic Diseases
Jefferson Medical College of Thomas Jefferson University
Philadelphia, Pennsylvania

William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts

Independent Clinical Reviewer

Debra L. Simmons, MD
Associate Professor of Medicine
University of Arkansas for Medical Sciences
Director, Endocrinology Training Program
Director, Arkansas Diabetes Program
Staff Physician, Central Arkansas Veterans Healthcare System
Little Rock, Arkansas

Financial Disclosure and Conflicts of Interest
According to the disclosure policy of Medical Education Collaborative, Inc (MEC) and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of MEC and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Goldstein: Grant/Research Support—AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., Inc, Novo Nordisk, sanofi aventis U.S., Takeda Pharmaceuticals North America, Inc; Consultant—GlaxoSmithKline, Merck & Co., Inc; Speaker’s Bureau—GlaxoSmithKline, Merck & Co., Inc, sanofi aventis U.S.
Dr. Cardarelli and Dr. Simmons disclosed no relevant financial relationships with any commercial interests.

Planning Committee employees of MEC, the accredited provider for this activity; Randy Robbin and John Savage, Princeton CME; and Jessica Brown, Kristin Dickie, and Mary Johnson, Princeton Media Communications have disclosed that they have no relevant financial relationships with any commercial interest.

MEC and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.

Privacy Policy
Medical Education Collaborative, Inc (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

MEC and Princeton CME maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Publisher’s Note
The opinions expressed in this educational activity are those of the presenters and are not attributable to the sponsor or the publisher, editor, or advisory board of Medical Education Collaborative, Inc (MEC) and Princeton Media Communications. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.